OMALIZUMAB Side Effects

7019244-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Malaise
on Sep 13, 2010 Female patient from SWITZERLAND , 39 years of age, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, malaise. Omalizumab dosage: 300 Mg, Q2w. During the same period patient was treated with PARIET (10 Mg, Bid) (View Pariet Review and Pariet Label ).

7013489-9 | Cytomegalovirus Infection, Eosinophilia, Pruritus, White Blood Cell Count Increased
Patient was taking Omalizumab (View Usage). Patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), eosinophilia, pruritus, white blood cell count increased on Sep 09, 2010 from SWITZERLAND Additional patient health information: Male patient , weighting 158.7 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 150 Mg, 1/month. During the same period patient was treated with QVAR 40 (Unk) (View Qvar 40 Review and Qvar 40 Label ), SEREVENT (Unk) (View Serevent Review and Serevent Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

7008679-5 | Status Asthmaticus
Adverse event was reported on Sep 14, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: Unk) was diagnosed with skin test, asthma (What is asthma?), hypersensitivity, rhinitis allergic and. Location: UNITED STATES , weighting 208.0 lb, After Omalizumab was administered, patient had the following side effects: status asthmaticus. During the same period patient was treated with PULMICORT (1 Mg, Bid) (View Pulmicort Review and Pulmicort Label ), ZYRTEC (10 Mg, Qd) (View Zyrtec Review and Zyrtec Label ), SINGULAIR (10 Mg, Qam) (View Singulair Review and Singulair Label ), NASONEX (1 Unk, Qd) (View Nasonex Review and Nasonex Label ), ASTEPRO (1 Unk, Qd) (View Astepro Review and Astepro Label ), XOPENEX (1.25 Unk, Prn) (View Xopenex Review and Xopenex Label ).

7008620-5 | Aspergillosis, Blood Pressure Abnormal, Cough, Dysphonia, Heart Rate Increased, Increased Bronchial Secretion, Nasal Congestion, Oropharyngeal Pain, Pulmonary Function Test Abnormal
on Sep 08, 2010 Male patient from SWITZERLAND , weighting 145.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, blood pressure abnormal, cough, dysphonia, heart rate increased, increased bronchial secretion, nasal congestion, oropharyngeal pain, pulmonary function test abnormal. Omalizumab dosage: 375 Mg, Q2w. During the same period patient was treated with NOVOTRIMEL (Unk) (View Novotrimel Review and Novotrimel Label ), TOBRAMYCIN (Unk) (View Tobramycin Review and Tobramycin Label ). Patient was hospitalized.


6992967-2 | Asthma
on Aug 30, 2010 Female patient from UNITED STATES , weighting 215.8 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: asthma (What is asthma?). Omalizumab dosage: Unk. During the same period patient was treated with XOPENEX (1.25 Unk, Unk) (View Xopenex Review and Xopenex Label ), PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ), FLOVENT (View Flovent Review and Flovent Label ), FORADIL (View Foradil Review and Foradil Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6971680-1 | Chronic Obstructive Pulmonary Disease
Patient was taking Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: chronic obstructive pulmonary disease on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 213.8 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: Unk. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized and became disabled.

6971679-5 | Asthma, Chest Pain, Cough, Dyspnoea, Eating Disorder, Oxygen Saturation Decreased, Pneumonia, Rales
Adverse event was reported on Aug 25, 2010 by a Male patient taking Omalizumab (View Usage) (Dosage: 300 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), chest pain (What is chest pain?), cough, dyspnoea, eating disorder (What is eating disorder?), oxygen saturation decreased, pneumonia (What is pneumonia?), rales. Patient was hospitalized.

6969330-3 | Asthma
on Aug 30, 2010 Female patient from UNITED STATES , weighting 215.8 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: asthma (What is asthma?). Omalizumab dosage: Unk Mg, Q4w. During the same period patient was treated with SINGULAIR (5 Mg, Qd) (View Singulair Review and Singulair Label ), XOPENEX (1.25 Mg, Unk) (View Xopenex Review and Xopenex Label ), PULMICORT (0.5 Mg, Unk) (View Pulmicort Review and Pulmicort Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6966325-0 | Inguinal Hernia
on Aug 31, 2010 Male patient from UNITED STATES , weighting 5.60 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: inguinal hernia. Omalizumab dosage: .

6966303-1 | Asthma, Blood Pressure Increased, Bone Debridement, Bone Pain, Bronchitis, Bronchospasm, Cough, Dizziness, Dyspnoea
Patient was taking Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), blood pressure increased, bone debridement, bone pain, bronchitis (What is bronchitis?), bronchospasm, cough, dizziness (What is dizziness?), dyspnoea on Aug 23, 2010 from SWITZERLAND Additional patient health information: Male patient , weighting 152.1 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 375 Mg, Q2w. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CALCITONIN (View Calcitonin Review and Calcitonin Label ), PREDNISONE (60 Mg, Unk) (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6963509-2 | Asthma
Adverse event was reported on Aug 25, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: Unk) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 215.8 lb, Patient had the following side effects: asthma (What is asthma?). During the same period patient was treated with XOPENEX (1.25 Unk, Unk) (View Xopenex Review and Xopenex Label ), PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ), FLOVENT (View Flovent Review and Flovent Label ), FORADIL (View Foradil Review and Foradil Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6961758-0 | Anaphylactic Reaction
on Aug 24, 2010 Female patient from UNITED STATES , weighting 224.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: anaphylactic reaction. Omalizumab dosage: Unk. During the same period patient was treated with ALBUTEROL (2 Puff, Prn) (View Albuterol Review and Albuterol Label ), ASMANEX TWISTHALER (3 Puff, Bid) (View Asmanex Twisthaler Review and Asmanex Twisthaler Label ).

6959402-1 | Asthma
on Aug 25, 2010 Female patient from UNITED STATES , weighting 215.8 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). Omalizumab dosage: Unk Mg, Q4w. During the same period patient was treated with SINGULAIR (5 Mg, Qd) (View Singulair Review and Singulair Label ), XOPENEX (1.25 Mg, Unk) (View Xopenex Review and Xopenex Label ), PULMICORT (0.5 Mg, Unk) (View Pulmicort Review and Pulmicort Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6956826-3 | Central Nervous System Inflammation, Csf Oligoclonal Band Present, Demyelination, Dysarthria, Hemiparesis
Patient was taking Omalizumab (View Usage). Patient had the following side effects: central nervous system inflammation, csf oligoclonal band present, demyelination, dysarthria, hemiparesis on Aug 18, 2010 from SWITZERLAND Additional patient health information: Female patient , 49 years of age, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 1 Df, 1/month. Patient was hospitalized.

6956751-8 | Asthma
Adverse event was reported on Aug 25, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: Unk) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 215.8 lb, After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?). During the same period patient was treated with XOPENEX (1.25 Unk, Unk) (View Xopenex Review and Xopenex Label ), PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ), FLOVENT (View Flovent Review and Flovent Label ), FORADIL (View Foradil Review and Foradil Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6945814-9 | Chronic Obstructive Pulmonary Disease
on Aug 19, 2010 Female patient from UNITED STATES , weighting 213.8 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease. Omalizumab dosage: Unk. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized and became disabled.

6942923-5 | Anaphylactic Reaction
on Aug 19, 2010 Female patient from UNITED STATES , weighting 224.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: anaphylactic reaction. Omalizumab dosage: Unk. During the same period patient was treated with ALBUTEROL (2 Puff, Prn) (View Albuterol Review and Albuterol Label ), ASMANEX TWISTHALER (3 Puff, Bid) (View Asmanex Twisthaler Review and Asmanex Twisthaler Label ).

6941523-0 | Asthma
Patient was taking Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?) on Aug 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 215.8 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: Unk. During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), FLOVENT (View Flovent Review and Flovent Label ), FORADIL (View Foradil Review and Foradil Label ), SINGULAIR (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

6939432-6 | Chronic Obstructive Pulmonary Disease
Adverse event was reported on Aug 19, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: Unk) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 215.8 lb, Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX (View Xopenex Review and Xopenex Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized and became disabled.

6939028-6 | Asthma
on Aug 17, 2010 Female patient from UNITED STATES , weighting 195.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: asthma (What is asthma?). Omalizumab dosage: 150 Mg, Q4w. During the same period patient was treated with SINGULAIR (10 Mg, Unk) (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLONASE (View Flonase Review and Flonase Label ), ZYRTEC (10 Mg, Unk) (View Zyrtec Review and Zyrtec Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), XOPENEX (Unk) (View Xopenex Review and Xopenex Label ).

6934744-4 | Abdominal Pain Upper, Bronchitis, Chest Pain, Dyspnoea, Fall, Fatigue, Gastrooesophageal Reflux Disease, Haemoptysis
on Aug 09, 2010 Female patient from SWITZERLAND , weighting 136.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: abdominal pain upper, bronchitis (What is bronchitis?), chest pain (What is chest pain?), dyspnoea, fall (What is fall?), fatigue, gastrooesophageal reflux disease, haemoptysis. Omalizumab dosage: 300 Mg, 1/month. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ALVESCO (View Alvesco Review and Alvesco Label ), REACTINE (View Reactine Review and Reactine Label ).

6929068-5 |
Patient was taking Omalizumab (View Usage). on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 238.5 lb, was diagnosed with asthma (What is asthma?), dyspnoea, hypersensitivity, herpes zoster, blood cholesterol, blood pressure increased, fungal infection (What is fungal infection?) and. Omalizumab dosage: 300 Mg, Q4w. During the same period patient was treated with LEVALBUTEROL HCL (Unk) (View Levalbuterol Hcl Review and Levalbuterol Hcl Label ), FLUTICASONE PROPIONATE (Unk) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), HERPES ZOSTER VACCINE NOS (View Herpes Zoster Vaccine Nos Review and Herpes Zoster Vaccine Nos Label ), ROSUVASTATIN (Unk) (View Rosuvastatin Review and Rosuvastatin Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NYSTATIN (Unk) (View Nystatin Review and Nystatin Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), EPIPEN (Unk) (View Epipen Review and Epipen Label ).

6914714-2 | Aspergillosis, Blood Pressure Abnormal, Cough, Dysphonia, Heart Rate Increased, Increased Bronchial Secretion, Nasal Congestion, Oropharyngeal Pain, Pulmonary Function Test Abnormal
Adverse event was reported on Jul 26, 2010 by a Male patient taking Omalizumab (View Usage) (Dosage: 375 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 145.5 lb, Patient had the following side effects: aspergillosis, blood pressure abnormal, cough, dysphonia, heart rate increased, increased bronchial secretion, nasal congestion, oropharyngeal pain, pulmonary function test abnormal. During the same period patient was treated with NOVOTRIMEL (Unk) (View Novotrimel Review and Novotrimel Label ), TOBRAMYCIN (Unk) (View Tobramycin Review and Tobramycin Label ). Patient was hospitalized.

6880908-8 | Asthma, Blood Albumin Decreased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Cardiac Arrest, Haemoglobin Decreased, Neurosensory Hypoacusis
on Jul 14, 2010 Female patient from SWITZERLAND , weighting 125.7 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?), blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, cardiac arrest (What is cardiac arrest?), haemoglobin decreased, neurosensory hypoacusis. Omalizumab dosage: 150 Mg, 1/month. During the same period patient was treated with PULMICORT (Unk) (View Pulmicort Review and Pulmicort Label ).

6876993-X | Asthma
on Jul 20, 2010 Male patient from UNITED STATES , weighting 232.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). Omalizumab dosage: 150 Mg, 4/month. During the same period patient was treated with LEVETIRACETAM (Unk) (View Levetiracetam Review and Levetiracetam Label ), AMITRIPTYLINE HCL (50 Mg, Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PRIMIDONE (50 Mg, Unk) (View Primidone Review and Primidone Label ), DOCUSATE SODIUM (250 Mg, Unk) (View Docusate Sodium Review and Docusate Sodium Label ), TAMSULOSIN HCL (0.4 Mg, Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ALBUTEROL (90 A?g/hr, Unk) (View Albuterol Review and Albuterol Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), CLONAZEPAM (10 Mg, Unk) (View Clonazepam Review and Clonazepam Label ).

6876892-3 | Abortion Spontaneous
Patient was taking Omalizumab (View Usage). Patient had the following side effects: abortion spontaneous on Jul 12, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 300 Mg, 1/month. During the same period patient was treated with FLUTICASONE PROPIONATE (50 G, Unk) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), SALMETEROL (50 G, Unk) (View Salmeterol Review and Salmeterol Label ).

6867929-6 | Asthma
Adverse event was reported on Jul 14, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: 150 Mg, Q4w) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 195.3 lb, After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?). During the same period patient was treated with SINGULAIR (10 Mg, Unk) (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLONASE (View Flonase Review and Flonase Label ), ZYRTEC (10 Mg, Unk) (View Zyrtec Review and Zyrtec Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), XOPENEX (Unk) (View Xopenex Review and Xopenex Label ).

6849803-4 | Asthma
on Jul 08, 2010 Female patient from UNITED STATES , weighting 195.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). Omalizumab dosage: 150 Mg, Q4w.

6845548-5 | Abdominal Pain, Asthenia, Blood Pressure Decreased, Crying, Dyspnoea Exertional, Gastrointestinal Carcinoma, Gastrointestinal Disorder, Haematochezia, Heart Rate Increased
on May 08, 2009 Female patient from SWITZERLAND , weighting 92.98 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, blood pressure decreased, crying, dyspnoea exertional, gastrointestinal carcinoma, gastrointestinal disorder, haematochezia, heart rate increased. Omalizumab dosage: 300 Mg, Q2w. During the same period patient was treated with CORTISONE (View Cortisone Review and Cortisone Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

6844576-3 | Abdominal Pain Upper, Chest Discomfort, Dyspnoea, Erythema, Fatigue, Fibromyalgia, Injection Site Pruritus, Joint Swelling, Malaise
Patient was taking Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: abdominal pain upper, chest discomfort, dyspnoea, erythema, fatigue, fibromyalgia, injection site pruritus, joint swelling, malaise on Jun 30, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 174.2 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 375 Mg, Q2w.

6840718-4 | Insomnia, Lower Respiratory Tract Infection, Lung Infection, Pulmonary Congestion
Adverse event was reported on Jun 29, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: 375 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 188.9 lb, Patient experienced the following unwanted or unexpected effects: insomnia, lower respiratory tract infection, lung infection, pulmonary congestion.

6837705-9 | Abortion Spontaneous
on Jun 30, 2010 Female patient from UNITED STATES , weighting 191.8 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: abortion spontaneous. Omalizumab dosage: 375 Mg, Q2w. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ), SINGULAIR (View Singulair Review and Singulair Label ), PEPCID (View Pepcid Review and Pepcid Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), VALTREX (View Valtrex Review and Valtrex Label ), XOPENEX (View Xopenex Review and Xopenex Label ), PATADAY (View Pataday Review and Pataday Label ).

6836712-X | Asthma, Chest Pain, Cough, Dyspnoea, Oxygen Saturation Decreased, Pneumonia, Rib Fracture
on Jun 30, 2010 Male patient from SWITZERLAND , weighting 119.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?), chest pain (What is chest pain?), cough, dyspnoea, oxygen saturation decreased, pneumonia (What is pneumonia?), rib fracture. Omalizumab dosage: 300 Mg, Q2w. Patient was hospitalized.

6834004-6 | Bronchospasm
Patient was taking Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm on Jun 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 232.6 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 150 Mg, 4/month. During the same period patient was treated with LEVETIRACETAM (Unk) (View Levetiracetam Review and Levetiracetam Label ), AMITRIPTYLINE HCL (50 Mg, Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PRIMIDONE (50 Mg, Unk) (View Primidone Review and Primidone Label ), DOCUSATE SODIUM (250 Mg, Unk) (View Docusate Sodium Review and Docusate Sodium Label ), TAMSULOSIN HCL (0.4 Mg, Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ALBUTEROL (90 A?g/hr, Unk) (View Albuterol Review and Albuterol Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), CLONAZEPAM (10 Mg, Unk) (View Clonazepam Review and Clonazepam Label ).

6833997-0 | Bronchospasm
Adverse event was reported on Jun 30, 2010 by a Male patient taking Omalizumab (View Usage) (Dosage: Unk) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 232.6 lb, Patient had the following side effects: bronchospasm.

6832836-1 | Anxiety, Asthma, Chest Pain, Dysphonia, Productive Cough, Sleep Disorder, Tremor
on Jun 29, 2010 Female patient from SWITZERLAND , weighting 123.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: anxiety (What is anxiety?), asthma (What is asthma?), chest pain (What is chest pain?), dysphonia, productive cough, sleep disorder (What is sleep disorder?), tremor. Omalizumab dosage: 300 Mg, Q2w. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ALVESCO (View Alvesco Review and Alvesco Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

6832190-5 | Asthma, Lower Respiratory Tract Infection
on Jun 30, 2010 Female patient from SWITZERLAND , weighting 114.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), lower respiratory tract infection. Omalizumab dosage: 225 Mg, Q2w. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6831716-5 | Asthma, Lung Infection, Nasopharyngitis
Patient was taking Omalizumab (View Usage). Patient had the following side effects: asthma (What is asthma?), lung infection, nasopharyngitis on Jun 28, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 137.1 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 225 Mg, Q2w. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), SYMBICORT (Unk) (View Symbicort Review and Symbicort Label ), ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ).

6831714-1 | Asthma, Blood Pressure Increased, Bone Pain, Bronchitis, Cough, Debridement, Dizziness, Dyspnoea, Headache
Adverse event was reported on Jun 28, 2010 by a Male patient taking Omalizumab (View Usage) (Dosage: 375 Mg, Q2w) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 152.1 lb, After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?), blood pressure increased, bone pain, bronchitis (What is bronchitis?), cough, debridement, dizziness (What is dizziness?), dyspnoea, headache (What is headache?). During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CALCITONIN (View Calcitonin Review and Calcitonin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6824340-1 | Bronchitis, Cough, Dyspnoea, Hypersensitivity, Increased Viscosity Of Bronchial Secretion, Nasopharyngitis, Pneumonia, Rhinitis Allergic
on Jun 25, 2010 Female patient from SWITZERLAND , weighting 143.3 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), cough, dyspnoea, hypersensitivity, increased viscosity of bronchial secretion, nasopharyngitis, pneumonia (What is pneumonia?), rhinitis allergic. Omalizumab dosage: 375 Mg, Unk.

6823490-3 | Asthma
on Jun 30, 2010 Male patient from UNITED STATES , weighting 232.6 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: asthma (What is asthma?). Omalizumab dosage: 150 Mg, 4/month. During the same period patient was treated with LEVETIRACETAM (Unk) (View Levetiracetam Review and Levetiracetam Label ), AMITRIPTYLINE HCL (50 Mg, Unk) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PRIMIDONE (50 Mg, Unk) (View Primidone Review and Primidone Label ), DOCUSATE SODIUM (250 Mg, Unk) (View Docusate Sodium Review and Docusate Sodium Label ), TAMSULOSIN HCL (0.4 Mg, Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ALBUTEROL (90 A?g/hr, Unk) (View Albuterol Review and Albuterol Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), CLONAZEPAM (10 Mg, Unk) (View Clonazepam Review and Clonazepam Label ).

6813633-X | Dyspnoea, Fatigue
Patient was taking Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: dyspnoea, fatigue on Jun 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 225 Mg, Q2w.

6811435-1 | Asthma, Sputum Retention
Adverse event was reported on Jun 14, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: 150 Mg, 1/month) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), sputum retention. During the same period patient was treated with SALMETEROL XINAFOATE (Unk) (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), MIYA BM (Unk) (View Miya-bm Review and Miya-bm Label ), ERYTHROCIN LACTOBIONATE (Unk) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), GASTER (Unk) (View Gaster Review and Gaster Label ), LORMETAZEPAM (Unk) (View Lormetazepam Review and Lormetazepam Label ). Patient was hospitalized.

6810253-8 | Abdominal Pain Upper, Dyspnoea, Erythema, Fibromyalgia, Injection Site Pruritus, Joint Swelling, Musculoskeletal Chest Pain, Obstructive Airways Disorder
on Jun 17, 2010 Female patient from SWITZERLAND , weighting 174.2 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient had the following side effects: abdominal pain upper, dyspnoea, erythema, fibromyalgia, injection site pruritus, joint swelling, musculoskeletal chest pain, obstructive airways disorder. Omalizumab dosage: 375 Mg, Q2w.

6806907-X | Allergic Sinusitis, Asthma, Musculoskeletal Chest Pain, Polyp, Productive Cough, Skeletal Injury, Wheezing
on Jun 17, 2010 Male patient from SWITZERLAND , weighting 209.9 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: allergic sinusitis, asthma (What is asthma?), musculoskeletal chest pain, polyp, productive cough, skeletal injury, wheezing. Omalizumab dosage: 300 Mg, 1/month. During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6796130-X | Asthma, Cough, Dyspnoea, Laryngitis, Lower Respiratory Tract Infection, Productive Cough, Wheezing
Patient was taking Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), cough, dyspnoea, laryngitis, lower respiratory tract infection, productive cough, wheezing on Jun 14, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 150 Mg, 1/month. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6796123-2 | Asthma, Sputum Retention
Adverse event was reported on Jun 14, 2010 by a Female patient taking Omalizumab (View Usage) (Dosage: 150 Mg, 1/month) was diagnosed with asthma (What is asthma?) and. Location: SWITZERLAND , weighting 110.2 lb, Patient had the following side effects: asthma (What is asthma?), sputum retention. During the same period patient was treated with SALMETEROL XINAFOATE (Unk) (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), MIYA BM (Unk) (View Miya-bm Review and Miya-bm Label ), ERYTHROCIN LACTOBIONATE (Unk) (View Erythrocin Lactobionate Review and Erythrocin Lactobionate Label ), GASTER (Unk) (View Gaster Review and Gaster Label ), LORMETAZEPAM (Unk) (View Lormetazepam Review and Lormetazepam Label ). Patient was hospitalized.

6795415-0 | Asthma, Blood Pressure Increased, Bone Pain, Bronchitis, Cough, Debridement, Dizziness, Dyspnoea, Headache
on Jun 14, 2010 Male patient from SWITZERLAND , weighting 152.1 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). After Omalizumab was administered, patient had the following side effects: asthma (What is asthma?), blood pressure increased, bone pain, bronchitis (What is bronchitis?), cough, debridement, dizziness (What is dizziness?), dyspnoea, headache (What is headache?). Omalizumab dosage: 375 Mg, Q2w. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CALCITONIN (View Calcitonin Review and Calcitonin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6791308-3 | Aortic Aneurysm Rupture, Hypoaesthesia, Shock
on Jun 10, 2010 Male patient from SWITZERLAND , weighting 145.5 lb, was diagnosed with asthma (What is asthma?) and was treated with Omalizumab (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm rupture, hypoaesthesia, shock. Omalizumab dosage: 300 Mg, 1/month. During the same period patient was treated with DIOVAN (Unk) (View Diovan Review and Diovan Label ).

6786868-2 | Bronchitis, Chest Pain, Haemoptysis, Sputum Discoloured
Patient was taking Omalizumab (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), chest pain (What is chest pain?), haemoptysis, sputum discoloured on Jun 11, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 136.0 lb, was diagnosed with asthma (What is asthma?) and. Omalizumab dosage: 300 Mg, 1/month. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ALVESCO (View Alvesco Review and Alvesco Label ), REACTINE (View Reactine Review and Reactine Label ).